Drugs

The NIJ Forensic Science Research and Development Symposium is an open meeting where attendees can learn about NIJ-funded research across a variety of forensic science areas. This is one of four videos from the 2022 symposium, which was held March 1-2, 2022.

Presentations include - 

This session busts the myth that new toxicology screening tools can fully replace traditional toxicology testing. The session discusses the appropriate integration of current rapid toxicology screening tools into MEC offices as a method of triaging cases, rather than a determination of toxicology related causes of deaths.

Identification of novel psychoactive substances (NPS) based on comparisons of electron-ionization (EI) mass spectra continues to pose challenges in seized drug analysis. In this webinar, a method to statistically compare EI mass spectra is described, and an application of the method to distinguish several structural and positional isomers of NPS analogs are demonstrated.

This webinar was hosted by the NIJ Forensic Technology Center of Excellence on July 25, 2024. 

The NIJ Forensic Science Research and Development Symposium is an open meeting where attendees can learn about NIJ-funded research across a variety of forensic science areas. 

This workshop explores the impact inconsistent drug analysis reporting has on public health and public trust. The value and implementation of the Global Uniform Analysis and Reporting of Drug-Related Substances (GUARDS) innovative methodology in over 200 instruments across United States Drug Enforcement Administration (DEA) laboratories are presented, as well as the efforts of other labs of the U.S. Customs and Border Protection (CBP) and Illinois State Police.

Of recent, forensic toxicology laboratories have been grappling with the emergence of tetrahydrocannabinol isomers within biological specimens. Traditional methodologies are often inadequate in the separation of Δ9-tetrahydrocannabinol and Δ8-tetrahydrocannabinol, which are the most common isomers identified in forensic testing.

This presentation describes the nature of the merge of the e-cigarette and cannabis industries. Quality assurance issues as a result of the absence of regulation and oversight is described. Cases of self-reported adverse events and the challenges of cannabis product analysis are also discussed.

This webinar was hosted by the NIJ Forensic Technology Center of Excellence on June 29, 2023. 

With the passage of the 2018 Agricultural Improvement Act (Farm Bill), forensic laboratories have been tasked with differentiating seized cannabis samples as either hemp or marijuana. The new legislation declassified hemp as a Schedule 1 drug substance and defined it as cannabis containing 0.3 % or less of decarboxylated-Δ9-THC (total Δ9-THC). The National Institute of Standards and Technology (NIST) has been working to help forensic laboratories with these challenging measurements through the development of extraction protocols and analytical methods.

The reauthorization of hemp due to the Agriculture Improvement Act of 2018 (Farm Bill) has caused a proliferation of products that contain cannabidiol (CBD). While CBD is considered ‘legal’ under the Farm-Bill, there are concerns that the labeling of CBD products is inaccurate, and that the products may contain other cannabinoids, including Δ9-tetrahydrocannabinol (THC), the main psychoactive compound in marijuana. Other concerns include the potential for conversion of CBD to other cannabinoids during analysis of biological matrices and in acidic foods and beverages.